352 related articles for article (PubMed ID: 19095369)
21. Ferumoxtran-10 ultrasmall superparamagnetic iron oxide-enhanced diffusion-weighted imaging magnetic resonance imaging for detection of metastases in normal-sized lymph nodes in patients with bladder and prostate cancer: do we enter the era after extended pelvic lymph node dissection?
Fortuin AS; Meijer H; Thompson LC; Witjes JA; Barentsz JO
Eur Urol; 2013 Dec; 64(6):961-3; discussion 963. PubMed ID: 23972400
[No Abstract] [Full Text] [Related]
22. Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer.
Triantafyllou M; Studer UE; Birkhäuser FD; Fleischmann A; Bains LJ; Petralia G; Christe A; Froehlich JM; Thoeny HC
Eur J Cancer; 2013 Feb; 49(3):616-24. PubMed ID: 23084842
[TBL] [Abstract][Full Text] [Related]
23. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients.
Barentsz JO; Fütterer JJ; Takahashi S
Eur J Radiol; 2007 Sep; 63(3):369-72. PubMed ID: 17689215
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography.
Bellin MF; Lebleu L; Meric JB
Abdom Imaging; 2003; 28(2):155-63. PubMed ID: 12592461
[TBL] [Abstract][Full Text] [Related]
25. Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy.
Shih HA; Harisinghani M; Zietman AL; Wolfgang JA; Saksena M; Weissleder R
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1262-9. PubMed ID: 16253781
[TBL] [Abstract][Full Text] [Related]
26. Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR Imaging at 1.5 and 3.0 T: early experience.
Heesakkers RA; Fütterer JJ; Hövels AM; van den Bosch HC; Scheenen TW; Hoogeveen YL; Barentsz JO
Radiology; 2006 May; 239(2):481-7. PubMed ID: 16641354
[TBL] [Abstract][Full Text] [Related]
27. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging.
Saksena MA; Saokar A; Harisinghani MG
Eur J Radiol; 2006 Jun; 58(3):367-74. PubMed ID: 16472955
[TBL] [Abstract][Full Text] [Related]
28. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.
Birkhäuser FD; Studer UE; Froehlich JM; Triantafyllou M; Bains LJ; Petralia G; Vermathen P; Fleischmann A; Thoeny HC
Eur Urol; 2013 Dec; 64(6):953-60. PubMed ID: 23916692
[TBL] [Abstract][Full Text] [Related]
29. Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.
Tabatabaei S; Harisinghani M; McDougal WS
J Urol; 2005 Sep; 174(3):923-7; discussion 927. PubMed ID: 16093989
[TBL] [Abstract][Full Text] [Related]
30. [The rule of metastatic pelvic lymph node distribution in patients with early stage cervical carcinoma].
Zhang HY; Sheng XG; Zhong Y; Ma ZF; Ma YB; Liu NF; Chen YT; Wang YY
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):452-5. PubMed ID: 19024522
[TBL] [Abstract][Full Text] [Related]
31. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes.
Mack MG; Balzer JO; Straub R; Eichler K; Vogl TJ
Radiology; 2002 Jan; 222(1):239-44. PubMed ID: 11756732
[TBL] [Abstract][Full Text] [Related]
32. Pearls and pitfalls of MR lymphography in gynecologic malignancy.
Narayanan P; Iyngkaran T; Sohaib SA; Reznek RH; Rockall AG
Radiographics; 2009; 29(4):1057-69; discussion 1069-71. PubMed ID: 19605656
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer.
Rockall AG; Sohaib SA; Harisinghani MG; Babar SA; Singh N; Jeyarajah AR; Oram DH; Jacobs IJ; Shepherd JH; Reznek RH
J Clin Oncol; 2005 Apr; 23(12):2813-21. PubMed ID: 15837995
[TBL] [Abstract][Full Text] [Related]
34. Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging.
Thoeny HC; Froehlich JM; Triantafyllou M; Huesler J; Bains LJ; Vermathen P; Fleischmann A; Studer UE
Radiology; 2014 Oct; 273(1):125-35. PubMed ID: 24893049
[TBL] [Abstract][Full Text] [Related]
35. MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent.
Pannu HK; Wang KP; Borman TL; Bluemke DA
J Magn Reson Imaging; 2000 Dec; 12(6):899-904. PubMed ID: 11105028
[TBL] [Abstract][Full Text] [Related]
36. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10.
Harisinghani MG; Dixon WT; Saksena MA; Brachtel E; Blezek DJ; Dhawale PJ; Torabi M; Hahn PF
Radiographics; 2004; 24(3):867-78. PubMed ID: 15143236
[TBL] [Abstract][Full Text] [Related]
37. Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).
Sargos P; Guerif S; Latorzeff I; Hennequin C; Pommier P; Lagrange JL; Créhange G; Chapet O; de Crevoisier R; Azria D; Supiot S; Habibian M; Soulié M; Richaud P
Cancer Treat Rev; 2015 Dec; 41(10):814-20. PubMed ID: 26508669
[TBL] [Abstract][Full Text] [Related]
38. Overview of nanoparticle use in cancer imaging.
Islam T; Harisinghani MG
Cancer Biomark; 2009; 5(2):61-7. PubMed ID: 19414922
[TBL] [Abstract][Full Text] [Related]
39. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.
Heesakkers RA; Hövels AM; Jager GJ; van den Bosch HC; Witjes JA; Raat HP; Severens JL; Adang EM; van der Kaa CH; Fütterer JJ; Barentsz J
Lancet Oncol; 2008 Sep; 9(9):850-6. PubMed ID: 18708295
[TBL] [Abstract][Full Text] [Related]
40. Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes?
Froehlich JM; Triantafyllou M; Fleischmann A; Vermathen P; Thalmann GN; Thoeny HC
Contrast Media Mol Imaging; 2012; 7(3):346-55. PubMed ID: 22539405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
